Preventive Maintenance and Repair Service Agreement for Emulate Zoe CM1 and CM2 culture modules
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), specifically the Center for Drug Evaluation and Research (CDER), is conducting market research to identify qualified sources for a Preventive Maintenance and Repair Service Agreement for their Emulate Zoe CM1 and CM2 culture modules. This is a Sources Sought notice, not a request for proposal. The FDA is seeking small business capabilities to determine potential set-aside opportunities, though other businesses are also encouraged to respond. Capability statements are due by May 26, 2026.
Scope of Work
The requirement is for a one-year maintenance contract covering Emulate Zoe CM1 (serial numbers ZOE-CM1 00142, ZOE-CM1-00141) and CM2 (serial numbers ZOE-CM2-00237, ZOE-CM2 00235) culture modules and related equipment. Services include:
- One (1) scheduled on-site preventive maintenance visit per instrument annually, including consumables, labor, travel, and parts.
- Unlimited on-site corrective maintenance and repairs when issues cannot be resolved remotely within two business days, covering labor, travel, and parts.
- Services must be performed by Emulate Inc. trained and certified engineers following OEM specifications and using OEM-certified parts.
- Unlimited software and firmware updates and unlimited technical support (phone/email, M-F, excluding Federal Holidays).
- Access to the manufacturer's call center for technical assistance.
- Provision of service record reports after each visit.
- Maintenance must ensure proper functioning of equipment compatible with lung and blood-milk barriers' MPS chips, including specific Chip-S1 and Chip-R1 Basic Research Kits, Steriflip filters, ER-1/ER-2 Chip Activation Reagent systems, and compound distribution kits.
Contract & Timeline
- Type: Sources Sought / Market Research
- NAICS: 811210 - Electronic and Precision Equipment Repair and Maintenance ($34M size standard)
- Set-Aside: Market research to determine potential small business set-aside.
- Period of Performance: One year, anticipated July 15, 2026, to July 14, 2027.
- Place of Performance: FDA White Oak Campus, Silver Spring, MD.
- Response Due: May 26, 2026, by 13:00 hours Central Time.
- Published: May 18, 2026.
Response Requirements
Interested parties should submit capability statements including:
- Business details (name, SAM UEI, address, size status, POC).
- Sufficient descriptive literature demonstrating capability to meet all requirements.
- Three years of past performance for similar services.
- Capability to initiate on-site service and estimated historical response times.
- Available service/repair agreement plans.
- GSA Schedule, BIC, or AbilityOne contract information (if applicable).
- Section 508 compliance information (ACR/VPAT).
- Identification of any restrictive specifications.
- Subcontracting opportunities for small businesses (if large business).
- Standard commercial warranty and payment terms.
- Place of product manufacture/service performance (Buy American Act).
- Informational pricing.
Additional Notes
This notice is for market research purposes only and does not obligate the Government to award a contract. Responses will inform future acquisition strategy (e.g., set-aside, full and open, sole-source). No proprietary or sensitive information should be included. Responses must demonstrate capability, not merely affirm it.